Calendar I-Mab Deutsche Boerse AG

Equities

0VY

US44975P1030

Market Closed - Deutsche Boerse AG 02:10:17 2024-06-26 am EDT 5-day change 1st Jan Change
1.59 EUR +0.63% Intraday chart for I-Mab -2.45% -3.64%

Chart calendar I-Mab

470219ad9338d40b28d3e2a0b0220.3PXGubnEemdoBQozWNydyq4mF7Cp_vlJ5Hu6mW2IkNQ.q5aJy9ilNzAnc1BcFonW-flrJ9_Aj4wK0z_f9Q_5oqSJk6Dd9vMoFQU2fQ~1dd611af9ad6da91ded60e755ab2ba94

Upcoming events on I-Mab

2024-08-26 Q2 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)
2025-09-01 Q2 2025 Earnings Release (Projected)
2026-03-31 Q4 2025 Earnings Release (Projected)

Past events on I-Mab

2024-06-05 09:30 am Jefferies Global Healthcare Conference
2024-04-11 10:15 am Needham Healthcare Conference
2024-03-14 05:00 pm Q4 2023 Earnings Release
2023-11-30 08:30 am Piper Sandler Healthcare Conference
2023-11-14 05:30 am Jefferies London Healthcare Conference
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Poster #: 792
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract ID: 845
2023-10-23 06:00 am European Society for Medical Oncology Congress
2023-09-26 02:10 pm Cantor Global Healthcare Conference
2023-09-11 11:30 am H.C. Wainwright Global Investment Conference
2023-08-17 08:00 am Q2 2023 Earnings Call
2023-08-17 06:00 am Q2 2023 Earnings Release
2023-06-03 08:00 am American Society of Clinical Oncology Conference - Abstract No: 2570
2023-03-31 08:15 am Q4 2022 Earnings Call
2023-03-31 06:30 am Q4 2022 Earnings Release
2022-12-12 06:00 pm American Society of Hematology Meeting - Abstract ID: 4462
2022-12-12 06:00 pm American Society of Hematology Meeting - Abstract ID: 3974
2022-11-10 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract ID : 859
2022-11-10 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract ID: 1151
2022-09-12 European Society for Medical Oncology Congress - Abstract #3823

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,23
9,87
-57.18%
236
185
27.81%
13,8
84,4
-83.64%
-32,1
38,2
-183.99%
3,89
2,72
43.36%

0,75

EBITDA
Million USD
Released
Forecast
Spread
-206
-171
-20.02%
26,2
67,6
-61.22%
-311
-174
-78.68%
-268
-213
-26.01%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-206
-118
-74.27%
23,8
34,5
-31.11%
-325
-179
-81.39%
-272
-232
-17.28%
-174
-168
-3.59%

-152

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-205
-62,7
-226.47%
73,9
37,2
98.35%
-366
-194
-88.63%
-350
-246
-41.96%
-206
-200
-3.02%

-143

Net income
Million USD
Released
Forecast
Spread
-209
-62,7
-233.9%
72,0
33,7
113.85%
-366
-195
-88.03%
-350
-246
-42%
-206
-200
-3.02%

-143

EPS
USD
Released
Forecast
Spread
-65,4
-1,08
-5937.96%
1,06
0,32
231.56%
-2,10
-1,83
-14.61%
-4,24
-2,08
-103.95%
-2,33
-1,77
-31.75%

-1,44

Announcement Date31/03/2029/03/2129/03/2231/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 S1 2025 S2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
236
196
20.47%
2,75
11,2
-75.42%
5,32
0,00
-
11,0
73,0
-84.89%
3,60
0,00
-
3,60
0,00
-
7,74
20,0
-61.29%

0,00


0,00

-39,9
25,0
-259.46%

0,00


0,00

2,71
3,00
-9.63%
1,18
0,00
-

0,00


0,00


0,75


0,00


0,00


0,75


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-86,9
-64,3
-35.09%
118
112
5.15%
-159
-109
-45.31%
-73,8
-87,3
15.48%
-164
-55,4
-196.14%
-56,9
-88,8
35.9%
-56,9
-90,3
36.98%
-122
-153
19.97%

-87,6


-133

-149
-88,8
-67.95%

-53,9


-53,1

-92,6
-95,6
3.11%
-81,4
-84,7
3.84%

-43,8


-45,2


-85,3


-47,3


-48,2


-84,7


-48,6







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-82,5
-63,5
-29.92%
163
102
59.13%
-167
-130
-28.68%
-95,0
-87,3
-8.8%
-197
-81,5
-141.56%
-72,6
-88,8
18.22%
-72,6
-90,3
19.58%
-156
-169
7.61%

-87,6


-133


-112


-53,9


-53,1

-107
-113
5.57%
-99,9
-97,3
-2.69%

-43,8


-45,2


-78,5


-47,3


-48,2


-65,6


-48,6


-54,2


-54,2

Net income
Million USD
Released
Forecast
Spread
-82,5
-63,5
-29.92%
161
102
57.3%
-167
-130
-28.31%
-95,0
-87,3
-8.8%
-197
-81,5
-141.55%
-72,6
-88,8
18.22%
-72,6
-90,3
19.58%
-156
-169
7.61%

-87,6


-133


-112


-53,9


-53,1

-107
-113
5.57%
-99,9
-97,3
-2.69%

-43,8


-45,2


-78,5


-47,3


-48,2


-65,6


-48,6


-54,2


-54,2

EPS
USD
Released
Forecast
Spread
-1,56
-1,10
-41.6%
2,62
1,21
116.29%
-2,28
-1,25
-82.74%
-1,21
-0,51
-136.9%
-1,09
-1,28
14.54%
-0,88
-0,48
-83.73%
-0,88
-0,48
-82.59%
-1,90
-1,79
-5.99%

-0,47


-0,70

-2,34
-1,08
-116.67%

-0,28


-0,27

-1,28
-1,31
2.29%
-1,05
-0,85
-24.04%

-0,22


-0,22


-0,55


-0,23


-0,24


-0,48


-0,23


-0,25


-0,25

Announcement Date31/08/2029/03/2131/08/2129/03/2229/03/2210/11/2230/08/2230/08/22--31/03/23--17/08/2314/03/24---------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise